Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
2019 · The Lancet Oncology · 438 citations
https://doi.org/10.1016/s1470-2045(19)30395-x